From Surf Wiki (app.surf) — the open knowledge base
Ciclesonide
Chemical compound
Chemical compound
| Drugs.com =
| elimination_half-life =
Ciclesonide, sold under the brand name Omnaris among others, is a glucocorticoid used to treat asthma and allergic rhinitis.
Side effects of the medication include headache, nosebleeds, and inflammation of the nose and throat linings.
It was patented in 1990 and approved for medical use in 2005. The drug was approved for adults and children 12 and over by the US Food and Drug Administration in October 2006. It is on the World Health Organization's List of Essential Medicines.
Society and culture
Brand names
It is marketed under the brand names Alvesco for asthma and Omnaris, Omniair, Zetonna, and Alvesco for hay fever in the US and Canada.
References
References
- (8 November 2022). "Omnaris- ciclesonide spray".
- (16 February 2023). "Alvesco- ciclesonide aerosol, metered".
- (16 February 2023). "Zetonna- ciclesonide aerosol, metered".
- (16 September 2021). "Aservo Equihaler- ciclesonide spray, metered".
- (28 February 2020). "Aservo Equihaler EPAR".
- (May 2007). "The role of esterases in the metabolism of ciclesonide to desisobutyryl-ciclesonide in human tissue". Biochemical Pharmacology.
- (2006). "Analogue-based Drug Discovery". John Wiley & Sons.
- (23 October 2006). "FDA News Release. FDA Approves New Treatment for Allergies". [[Food and Drug Administration (United States).
- (2021). "World Health Organization model list of essential medicines: 22nd list (2021)". World Health Organization.
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about Ciclesonide — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report